ECONOMIC EVALUATION OF INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE

被引：0
|
作者：
Hughes, D. A. [1 ]
Kikuchi, T. [1 ]
Bodger, K. [2 ]
机构：
[1] Bangor Univ, Bangor, Gwynedd, Wales
[2] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73358-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [31] A retrospective comparison of infliximab versus adalimumab as induction therapy for crohn's disease
    Varma, P.
    Huang, C.
    Paul, E.
    Headon, B.
    Sparrow, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 108 - 109
  • [32] Crohn's disease: certolizumab, adalimumab demonstrate efficacy in prior users of infliximab
    不详
    FORMULARY, 2007, 42 (01) : 58 - 59
  • [33] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [34] Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
    Christine H Song
    Jaclyn A Quirt
    Jason K Lee
    Allergy, Asthma & Clinical Immunology, 8 (Suppl 1)
  • [35] DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENT
    Lachaine, J.
    Beauchemin, C.
    Goyette, A.
    Martel, M. J.
    VALUE IN HEALTH, 2011, 14 (03) : A182 - A182
  • [36] INFLIXIMAB-GRADED CHALLENGE IN A PATIENT WITH CROHN'S DISEASE AND ADALIMUMAB HYPERSENSITIVITY
    Song, C.
    Quirt, J.
    Lee, J. K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A43 - A43
  • [37] Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review
    Da, Wei
    Zhu, Jinshui
    Wang, Long
    Lu, Yunmin
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) : 885 - 891
  • [38] Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    Vander Cruyssen, B.
    Gils, A.
    De Vos, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 15 - 21
  • [39] Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
    Christensen, B.
    Sparrow, M. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (01) : 178 - 179
  • [40] Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. -C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    De Vos, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S274 - S274
12345